
National Research Corporation NRC
€ 14.92
-0.86%
Geschäftsbericht 2025
hinzugefügt 05.03.2026
National Research Corporation P/E 2011-2026 | NRC
P/E Jährlich National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.2 | 13.5 | 32.6 | 35.8 | 28.2 | 30.4 | 53 | 35.4 | 39.2 | 20.3 | 20.8 | 18.5 | 24.2 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 53 | 13.5 | 29.1 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 15.48 | -5.49 % | $ 468 M | ||
|
Biodesix
BDSX
|
-2.14 | $ 13.64 | -6.58 % | $ 1.77 B | ||
|
DarioHealth Corp.
DRIO
|
-0.787 | $ 8.45 | - | $ 33.7 M | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | $ 477.84 | -2.25 % | $ 180 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
IDEXX Laboratories
IDXX
|
48.3 | $ 565.93 | -1.28 % | $ 45.5 B | ||
|
Illumina
ILMN
|
-13.4 | $ 118.67 | -4.61 % | $ 18.9 B | ||
|
Trinity Biotech plc
TRIB
|
129 | $ 0.61 | -0.62 % | $ 61.9 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 238.69 | -2.47 % | $ 25.5 B | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 158.35 | -4.21 % | $ 7.85 B | ||
|
Organovo Holdings
ONVO
|
-1.25 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
0.761 | - | -16.95 % | $ 1.54 M | ||
|
Waters Corporation
WAT
|
30.6 | $ 291.81 | -2.91 % | $ 17.4 B | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.191 | $ 4.75 | 3.38 % | $ 2.55 M | ||
|
Personalis
PSNL
|
-3.12 | $ 6.55 | -10.52 % | $ 388 M | ||
|
PerkinElmer
PKI
|
52.3 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M | ||
|
Exagen
XGN
|
-3.51 | $ 2.68 | -4.12 % | $ 57.8 M | ||
|
Interpace Biosciences
IDXG
|
0.615 | $ 1.73 | 2.37 % | $ 7.59 M | ||
|
RadNet
RDNT
|
-302 | $ 56.85 | -4.31 % | $ 4.27 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Celcuity
CELC
|
-30.3 | $ 111.56 | -2.8 % | $ 5.22 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 6.54 | -0.3 % | $ 273 M | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 266.88 | -0.56 % | $ 22.2 B | ||
|
VolitionRx Limited
VNRX
|
-2.01 | $ 0.2 | 0.03 % | $ 19.2 M | ||
|
Psychemedics Corporation
PMD
|
-4.05 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-1.49 | $ 26.75 | -1.65 % | $ 34.7 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 17.11 | -2.06 % | $ 912 M | ||
|
Neuronetics
STIM
|
-2.08 | $ 1.4 | 5.26 % | $ 92.3 M | ||
|
Quotient Limited
QTNT
|
-1.65 | - | -11.32 % | $ 1.1 M |